07.11.2025 12:38
During a press conference where U.S. President Donald Trump announced agreements with weight loss drug manufacturers, the fainting of Gordon Findlay, Global Brand Director of Novo Nordisk, caused moments of panic. Dr. Mehmet Öz, who was present at the scene, provided the first aid to Findlay, while Trump later stated that Findlay's health was good.
U.S. President Donald Trump held a press conference at the White House to announce agreements with the weight loss drug manufacturers "Eli Lilly" and "Novo Nordisk," which turned into a scene of terrifying moments.
SUDDENLY FAINTED
During the speech of Eli Lilly CEO David Ricks, who spoke after Trump, Novo Nordisk's Global Brand Director Gordon Findlay suddenly fainted.
FIRST INTERVENTION BY MEHMET ÖZ
The first intervention for Findlay, who was about to fall to the ground, was made by Dr. Mehmet Öz, the Director of Medicare and Medicaid (CMS), who was present at the scene, while it was noteworthy that White House officials abruptly cut the live broadcast and evacuated the press members from the Oval Office.
"FAINTED BUT IS FINE"
In the press conference that continued after about 30 minutes, Trump provided information about Findlay's health status, stating, "One of the company representatives fainted. As you can see, he fell to the ground and is in good condition. They just sent him away, and he is under doctor's supervision. But he is fine."